6 results were returned
In the recent case of InterPharma Pty Ltd v Hospira Inc (No 5)  FCA 960 the Australian Federal Court has given patentees guidance as to novelty preserving practice in the conduct of clinical trials.
The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)
As Novel Coronavirus (COVID-19) continues to spread across the globe, in an effort to prepare for all eventualities, on 10 February 2020, the UK Government passed into law The Health Protection (Coronavirus) Regulations ...
Cannabidiol ('CBD') has had an increasing consumer interest over recent years due to the range of CBD-based products that are now available and the purported benefits these products give to the consumer's health and ...
The COVID-19 pandemic has been a catalyst for change. As businesses around the world continue to adjust to the new normal and keep abreast of the rapidly changing rules and operational capabilities, business leaders ...
Competition law is (sometimes) perceived to be a barrier for cooperation and progress towards a more sustainable economy. This outlook 2021 explores the current available leeway under competition law for sustainability ...